Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00832871 · ClinicalTrials.gov registry record · NA
Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers
A NA study, sponsored by New Mexico Cancer Research Alliance.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT00832871: Clinical Trial NA study, sponsored by New Mexico Cancer Research Alliance.
NCT00832871 is a NA study that was terminated before completion, run by New Mexico Cancer Research Alliance. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00832871, a NA study, was terminated before completion, sponsored by New Mexico Cancer Research Alliance.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to see if mifepristone prevents worsening of your cancer. Mifepristone is an antiprogesterone agent, a drug which blocks female hormones, that is commonly used for the termination of pregnancies. It has not been approved by the Food and Drug Administration for use in the treatment of cancer. It is unlicensed in the United States for your condition. However, previous work has indicated that mifepristone may be useful due to how it works. It is being made available for use in the United States for compassionate use through the Feminist Majority Foundation.
Primary Outcome
The time from the date of response (not the beginning of treatment unless there is stable disease) to disease progression. Response and progression are evaluated according to Response Evaluation Criteria in Solid Tumors (RECIST) (version 1.0). Target lesions are assessed by computerized tomography (CT) or magnetic resonance imaging (MRI): Complete Response (CR), Disappearance of all target lesions; Partial Response (PR), \>=30% decrease in the sum of the longest diameter of target lesions; Stabl
Interventions
- DRUG Mifepristone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2008-11 |
| Est. Completion | 2015-12 |
| Phase | NA |
Why NCT00832871 stopped before completion
NCT00832871 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Mifepristone is the first listed.
NCT00832871 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00832871 about?
NCT00832871 is a clinical study titled "Compassionate Use of Mifepristone in Brain/Nervous System and Other Cancers". The purpose of this study is to see if mifepristone prevents worsening of your cancer. Mifepristone is an antiprogesterone agent, a drug which blocks female hormones, that is commonly used for the termination of pregnancies. It has not been approved by the Food and Drug Administration for use in the...
What is the current status of trial NCT00832871?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2008-11. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00832871?
The interventions under investigation include: Mifepristone (DRUG).
Who is sponsoring clinical trial NCT00832871?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00832871's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia